{"transactions":[{"id":4617864,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-09-15T20:10:07.000Z","date":"2026-09-11","kind":"exercise","planned":false,"acquired":false,"shares":18333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in a series of three successive equal annual installments beginning on the one-year anniversary of September 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in a series of three successive equal annual installments beginning on the one-year anniversary of September 11, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":18333},"source":{"system":"sec-edgar","filing":"0001197350-26-000010","document":"form4-09152026_040901.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000119735026000010/form4-09152026_040901.xml","form_type":"4"}},{"id":4617863,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-15T20:10:07.000Z","date":"2026-09-14","kind":"sale","planned":false,"acquired":false,"shares":9943,"price":98.37,"value":978092.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":44745,"source":{"system":"sec-edgar","filing":"0001197350-26-000010","document":"form4-09152026_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000119735026000010/form4-09152026_040901.xml","form_type":"4"}},{"id":4617862,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-15T20:10:07.000Z","date":"2026-09-11","kind":"exercise","planned":false,"acquired":true,"shares":18333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."}],"balance_after":54688,"source":{"system":"sec-edgar","filing":"0001197350-26-000010","document":"form4-09152026_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000119735026000010/form4-09152026_040901.xml","form_type":"4"}},{"id":689314,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-08-12T21:14:43.000Z","date":"2026-08-11","kind":"sale","planned":true,"acquired":false,"shares":6001,"price":99.9016,"value":599509.5016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 9, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":". The weighted average sale price for the transaction reported was $99.901633, and the range of prices were between $99.90 and $99.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 175 shares of common stock that were acquired by the Reporting Person on May 10, 2026, pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":36355,"source":{"system":"sec-edgar","filing":"0001197350-26-000009","document":"form4-08122026_090835.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000119735026000009/form4-08122026_090835.xml","form_type":"4"}},{"id":712669,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-07-08T21:07:31.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":300,"price":124.94,"value":37482.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 9, 2026."}],"balance_after":42181,"source":{"system":"sec-edgar","filing":"0001197350-26-000008","document":"form4-07082026_090727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000119735026000008/form4-07082026_090727.xml","form_type":"4"}},{"id":712668,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-07-08T21:07:31.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":528,"price":123.84,"value":65387.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 9, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":". The weighted average sale price for the transaction reported was $123.84, and the range of prices were between $123.285 and $124.27. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":42481,"source":{"system":"sec-edgar","filing":"0001197350-26-000008","document":"form4-07082026_090727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000119735026000008/form4-07082026_090727.xml","form_type":"4"}},{"id":712667,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-07-08T21:07:31.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":1048,"price":122.43,"value":128306.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 9, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":". The weighted average sale price for the transaction reported was $122.43, and the range of prices were between $122.235 and $123.10. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":43009,"source":{"system":"sec-edgar","filing":"0001197350-26-000008","document":"form4-07082026_090727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000119735026000008/form4-07082026_090727.xml","form_type":"4"}},{"id":712666,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-07-08T21:07:31.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":3124,"price":121.67,"value":380097.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 9, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":". The weighted average sale price for the transaction reported was $121.67, and the range of prices were between $121.13 and $122.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":44057,"source":{"system":"sec-edgar","filing":"0001197350-26-000008","document":"form4-07082026_090727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000119735026000008/form4-07082026_090727.xml","form_type":"4"}},{"id":742203,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T01:17:02.000Z","date":"2026-06-09","kind":"sale","planned":false,"acquired":false,"shares":20454,"price":2.6,"value":53180.4,"ownership":{"direct":true},"balance_after":261679,"source":{"system":"sec-edgar","filing":"0001193125-26-268227","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000119312526268227/ownership.xml","form_type":"4"}},{"id":741424,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T17:49:03.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the Grant Date or (ii) the date of the Company's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on such vesting date."}],"balance_after":21000,"derivative":{"exercise_price":1.23,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001193125-26-267189","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197350/000119312526267189/ownership.xml","form_type":"4"}},{"id":744707,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-06-10T01:21:05.000Z","date":"2026-06-09","kind":"exercise","planned":true,"acquired":false,"shares":2393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4th of the shares vested one year after January 23, 2024 (the \"Vesting Commencement Date\") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."}],"balance_after":26653,"derivative":{"exercise_price":26.49,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":2393},"source":{"system":"sec-edgar","filing":"0001197350-26-000007","document":"form4-06102026_010600.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000119735026000007/form4-06102026_010600.xml","form_type":"4"}},{"id":744706,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-06-10T01:21:05.000Z","date":"2026-06-09","kind":"exercise","planned":true,"acquired":true,"shares":2393,"price":26.49,"value":63390.57,"ownership":{"direct":true},"balance_after":47181,"source":{"system":"sec-edgar","filing":"0001197350-26-000007","document":"form4-06102026_010600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000119735026000007/form4-06102026_010600.xml","form_type":"4"}},{"id":744705,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-06-10T01:21:05.000Z","date":"2026-06-08","kind":"sale","planned":true,"acquired":false,"shares":1567,"price":95.12,"value":149053.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 9, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":". The weighted average sale price for the transaction reported was $95.12, and the range of prices were between $94.62 and $95.44. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":44788,"source":{"system":"sec-edgar","filing":"0001197350-26-000007","document":"form4-06102026_010600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000119735026000007/form4-06102026_010600.xml","form_type":"4"}},{"id":744704,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-06-10T01:21:05.000Z","date":"2026-06-08","kind":"sale","planned":true,"acquired":false,"shares":1175,"price":93.95,"value":110391.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 9, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":". The weighted average sale price for the transaction reported was $93.95, and the range of prices were between $93.49 and $94.47. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":46355,"source":{"system":"sec-edgar","filing":"0001197350-26-000007","document":"form4-06102026_010600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000119735026000007/form4-06102026_010600.xml","form_type":"4"}},{"id":744703,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-06-10T01:21:05.000Z","date":"2026-06-08","kind":"sale","planned":true,"acquired":false,"shares":2258,"price":92.84,"value":209632.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 9, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":". The weighted average sale price for the transaction reported was $92.84, and the range of prices were between $92.485 and $93.31. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":47530,"source":{"system":"sec-edgar","filing":"0001197350-26-000007","document":"form4-06102026_010600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000119735026000007/form4-06102026_010600.xml","form_type":"4"}},{"id":755790,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T23:54:44.000Z","date":"2026-06-02","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSUs granted pursuant to the Issuer's 2024 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":282133,"source":{"system":"sec-edgar","filing":"0001193125-26-254116","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000119312526254116/ownership.xml","form_type":"4"}},{"id":778802,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-05-14T20:25:14.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":5550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable on the anniversary of the grant date, subject to continuous service as a director."}],"balance_after":5550,"derivative":{"exercise_price":30.14,"exercise_date":"2027-05-13","expiration_date":"2036-05-12","underlying":"Common Stock","underlying_shares":5550},"source":{"system":"sec-edgar","filing":"0001193125-26-224131","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197350/000119312526224131/ownership.xml","form_type":"4"}},{"id":838104,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Performance Restricted Stock Units","published_at":"2026-03-17T23:30:20.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":13334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares vest as follows:  2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares vest as follows:  2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027."}],"balance_after":6666,"derivative":{"underlying":"Common Stock","underlying_shares":13334},"source":{"system":"sec-edgar","filing":"0001197350-26-000006","document":"form4-03172026_070311.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000119735026000006/form4-03172026_070311.xml","form_type":"4"}},{"id":838103,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-17T23:30:20.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":7287,"price":91.9779,"value":670242.9573,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to cover tax withholding obligations associated with the vesting of the performance restricted stock units."}],"balance_after":49788,"source":{"system":"sec-edgar","filing":"0001197350-26-000006","document":"form4-03172026_070311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000119735026000006/form4-03172026_070311.xml","form_type":"4"}},{"id":838102,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-17T23:30:20.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":13334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":57075,"source":{"system":"sec-edgar","filing":"0001197350-26-000006","document":"form4-03172026_070311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000119735026000006/form4-03172026_070311.xml","form_type":"4"}},{"id":927027,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Performance Restricted Stock Units","published_at":"2026-01-30T23:30:08.000Z","date":"2026-01-28","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 23, 2024, the reporting person was granted performance restricted stock units (\"PSUs\") which vest upon satisfaction of certain performance criteria. On January 28, 2026, performance criteria were determined to have been met. The shares subject to the PSUs vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 23, 2024, the reporting person was granted performance restricted stock units (\"PSUs\") which vest upon satisfaction of certain performance criteria. On January 28, 2026, performance criteria were determined to have been met. The shares subject to the PSUs vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001197350-26-000004","document":"form4-01302026_060105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000119735026000004/form4-01302026_060105.xml","form_type":"4"}},{"id":927026,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-30T23:30:08.000Z","date":"2026-01-28","kind":"grant","planned":false,"acquired":true,"shares":11760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 28, 2026 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 28, 2026 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."}],"balance_after":11760,"derivative":{"underlying":"Common Stock","underlying_shares":11760},"source":{"system":"sec-edgar","filing":"0001197350-26-000004","document":"form4-01302026_060105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000119735026000004/form4-01302026_060105.xml","form_type":"4"}},{"id":927025,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-30T23:30:08.000Z","date":"2026-01-28","kind":"grant","planned":false,"acquired":true,"shares":18140,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest one year after January 28, 2026 (the \"Vesting Commencement Date\") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."}],"balance_after":18140,"derivative":{"exercise_price":100.85,"expiration_date":"2036-01-27","underlying":"Common Stock","underlying_shares":18140},"source":{"system":"sec-edgar","filing":"0001197350-26-000004","document":"form4-01302026_060105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000119735026000004/form4-01302026_060105.xml","form_type":"4"}},{"id":930093,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-27T21:30:15.000Z","date":"2026-01-23","kind":"exercise","planned":false,"acquired":false,"shares":2667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."}],"balance_after":2666,"derivative":{"underlying":"Common Stock","underlying_shares":2667},"source":{"system":"sec-edgar","filing":"0001197350-26-000002","document":"form4-01272026_040108.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000119735026000002/form4-01272026_040108.xml","form_type":"4"}},{"id":930092,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-27T21:30:15.000Z","date":"2026-01-26","kind":"sale","planned":false,"acquired":false,"shares":1053,"price":96.192,"value":101290.176,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."}],"balance_after":43741,"source":{"system":"sec-edgar","filing":"0001197350-26-000002","document":"form4-01272026_040108.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000119735026000002/form4-01272026_040108.xml","form_type":"4"}},{"id":930091,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-27T21:30:15.000Z","date":"2026-01-23","kind":"exercise","planned":false,"acquired":true,"shares":2667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."}],"balance_after":44794,"source":{"system":"sec-edgar","filing":"0001197350-26-000002","document":"form4-01272026_040108.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000119735026000002/form4-01272026_040108.xml","form_type":"4"}},{"id":932395,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-23T22:30:10.000Z","date":"2026-01-21","kind":"exercise","planned":false,"acquired":false,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 21, 2025 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 21, 2025 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."}],"balance_after":6666,"derivative":{"underlying":"Common Stock","underlying_shares":3334},"source":{"system":"sec-edgar","filing":"0001197350-26-000001","document":"form4-01232026_050106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000119735026000001/form4-01232026_050106.xml","form_type":"4"}},{"id":932394,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-23T22:30:10.000Z","date":"2026-01-22","kind":"sale","planned":false,"acquired":false,"shares":1421,"price":93.3252,"value":132615.1092,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."}],"balance_after":42127,"source":{"system":"sec-edgar","filing":"0001197350-26-000001","document":"form4-01232026_050106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000119735026000001/form4-01232026_050106.xml","form_type":"4"}},{"id":932393,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-23T22:30:10.000Z","date":"2026-01-21","kind":"exercise","planned":false,"acquired":true,"shares":3334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 269 shares of common stock that were acquired by the Reporting Person on November 10, 2025, pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":43548,"source":{"system":"sec-edgar","filing":"0001197350-26-000001","document":"form4-01232026_050106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000119735026000001/form4-01232026_050106.xml","form_type":"4"}},{"id":1041640,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-09-13T00:00:05.000Z","date":"2025-09-11","kind":"exercise","planned":false,"acquired":false,"shares":18333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in a series of three successive equal annual installments beginning on the one-year anniversary of September 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in a series of three successive equal annual installments beginning on the one-year anniversary of September 11, 2023."}],"balance_after":18333,"derivative":{"underlying":"Common Stock","underlying_shares":18333},"source":{"system":"sec-edgar","filing":"0001415889-25-024462","document":"form4-09122025_080902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925024462/form4-09122025_080902.xml","form_type":"4"}},{"id":1041639,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-09-13T00:00:05.000Z","date":"2025-09-12","kind":"sale","planned":false,"acquired":false,"shares":9578,"price":76.01,"value":728023.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":39945,"source":{"system":"sec-edgar","filing":"0001415889-25-024462","document":"form4-09122025_080902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925024462/form4-09122025_080902.xml","form_type":"4"}},{"id":1041638,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-09-13T00:00:05.000Z","date":"2025-09-11","kind":"exercise","planned":false,"acquired":true,"shares":18333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."}],"balance_after":49523,"source":{"system":"sec-edgar","filing":"0001415889-25-024462","document":"form4-09122025_080902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925024462/form4-09122025_080902.xml","form_type":"4"}},{"id":1069014,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-08-13T00:00:03.000Z","date":"2025-08-12","kind":"exercise","planned":false,"acquired":false,"shares":2954,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the shares vested one year after January 23, 2024 (the \"Vesting Commencement Date\") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."}],"balance_after":29046,"derivative":{"exercise_price":26.49,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":2954},"source":{"system":"sec-edgar","filing":"0001415889-25-021522","document":"form4-08122025_110857.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925021522/form4-08122025_110857.xml","form_type":"4"}},{"id":1069013,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-08-13T00:00:03.000Z","date":"2025-08-12","kind":"exercise","planned":false,"acquired":true,"shares":2954,"price":26.49,"value":78251.46,"ownership":{"direct":true},"balance_after":31190,"source":{"system":"sec-edgar","filing":"0001415889-25-021522","document":"form4-08122025_110857.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925021522/form4-08122025_110857.xml","form_type":"4"}},{"id":1069012,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-08-13T00:00:03.000Z","date":"2025-08-11","kind":"sale","planned":false,"acquired":false,"shares":8000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average sale price for the transaction reported was $65.50, and the range of prices were between $65.31 and $66.00. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 290 shares of Common Stock that were acquired by the Reporting Person on May 10, 2025 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":28236,"source":{"system":"sec-edgar","filing":"0001415889-25-021522","document":"form4-08122025_110857.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925021522/form4-08122025_110857.xml","form_type":"4"}},{"id":1113072,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T20:33:13.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":8572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the Grant Date or (ii) the date of the Company's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on such vesting date."}],"balance_after":8572,"derivative":{"exercise_price":1.57,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":8572},"source":{"system":"sec-edgar","filing":"0000950170-25-085483","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197350/000095017025085483/ownership.xml","form_type":"4"}},{"id":1123602,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T22:31:20.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSUs granted pursuant to the Issuer's 2024 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":222133,"source":{"system":"sec-edgar","filing":"0000950170-25-081843","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000095017025081843/ownership.xml","form_type":"4"}},{"id":1147155,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2025-05-15T21:29:26.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":1333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable on the anniversary of the grant date, subject to continuous service as a director."}],"balance_after":1333,"derivative":{"exercise_price":6.5,"exercise_date":"2026-05-14","expiration_date":"2035-05-14","underlying":"Common Stock","underlying_shares":1333},"source":{"system":"sec-edgar","filing":"0001593968-25-000613","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197350/000159396825000613/primary_01.xml","form_type":"4"}},{"id":1281631,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-05T21:24:01.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33.33% of the shares subject to this option shall vest and become exercisable on February 3, 2026, with the remainder vesting in 24 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":42000,"derivative":{"exercise_price":2.51,"expiration_date":"2035-02-02","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0000950170-25-014528","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197350/000095017025014528/ownership.xml","form_type":"4"}},{"id":1294537,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-01-27T21:49:49.000Z","date":"2025-01-23","kind":"exercise","planned":false,"acquired":false,"shares":2667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."}],"balance_after":5333,"derivative":{"underlying":"Common Stock","underlying_shares":2667},"source":{"system":"sec-edgar","filing":"0001415889-25-002136","document":"form4-01272025_090146.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925002136/form4-01272025_090146.xml","form_type":"4"}},{"id":1294536,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-27T21:49:49.000Z","date":"2025-01-23","kind":"exercise","planned":false,"acquired":true,"shares":2667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."}],"balance_after":35946,"source":{"system":"sec-edgar","filing":"0001415889-25-002136","document":"form4-01272025_090146.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925002136/form4-01272025_090146.xml","form_type":"4"}},{"id":1296441,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-01-23T22:53:31.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 21, 2025 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 21, 2025 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-25-001953","document":"form4-01232025_100126.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925001953/form4-01232025_100126.xml","form_type":"4"}},{"id":1296440,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-23T22:53:31.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest one year after January 21, 2025 (the \"Vesting Commencement Date\") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."}],"balance_after":40000,"derivative":{"exercise_price":47.98,"expiration_date":"2035-01-20","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-25-001953","document":"form4-01232025_100126.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925001953/form4-01232025_100126.xml","form_type":"4"}},{"id":1331304,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-17T01:37:31.000Z","date":"2024-12-12","kind":"sale","planned":false,"acquired":false,"shares":20000,"price":1.785,"value":35700.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.78 to $1.79 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth."}],"balance_after":162133,"source":{"system":"sec-edgar","filing":"0000950170-24-136863","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000095017024136863/ownership.xml","form_type":"4"}},{"id":1365194,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-11-14T21:34:32.000Z","date":"2024-11-08","kind":"grant","planned":false,"acquired":true,"shares":475,"price":21.046,"value":9996.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 475 shares by the Reporting Person on November 8, 2024 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":33279,"source":{"system":"sec-edgar","filing":"0001415889-24-026870","document":"form4-11142024_091128.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924026870/form4-11142024_091128.xml","form_type":"4"}},{"id":1408698,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-09-12T20:18:50.000Z","date":"2024-09-11","kind":"exercise","planned":false,"acquired":false,"shares":18334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in a series of three successive equal annual installments beginning on the one-year anniversary of September 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in a series of three successive equal annual installments beginning on the one-year anniversary of September 11, 2023."}],"balance_after":36666,"derivative":{"underlying":"Common Stock","underlying_shares":18334},"source":{"system":"sec-edgar","filing":"0001415889-24-023289","document":"form4-09122024_080946.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924023289/form4-09122024_080946.xml","form_type":"4"}},{"id":1408697,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-09-12T20:18:50.000Z","date":"2024-09-11","kind":"exercise","planned":false,"acquired":true,"shares":18334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."}],"balance_after":32804,"source":{"system":"sec-edgar","filing":"0001415889-24-023289","document":"form4-09122024_080946.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924023289/form4-09122024_080946.xml","form_type":"4"}},{"id":1420662,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2024-08-28T23:14:14.000Z","date":"2024-08-27","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option vest in equal monthly installments over a one year period following March 28, 2024."}],"balance_after":10000,"derivative":{"exercise_price":4.16,"expiration_date":"2034-08-26","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-24-022508","document":"form4-08282024_110809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197350/000141588924022508/form4-08282024_110809.xml","form_type":"4"}},{"id":1488186,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2024-06-07T00:19:42.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":1333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable on the anniversary of the grant date, subject to continuous service as a director."}],"balance_after":1333,"derivative":{"exercise_price":11,"exercise_date":"2025-06-05","expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":1333},"source":{"system":"sec-edgar","filing":"0001593968-24-000827","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197350/000159396824000827/primary_01.xml","form_type":"4"}},{"id":1488883,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T23:52:59.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":5,"value":200000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":182133,"source":{"system":"sec-edgar","filing":"0001209191-24-005820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919124005820/doc4.xml","form_type":"4"}},{"id":1514336,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-05-16T20:30:48.000Z","date":"2024-05-10","kind":"grant","planned":false,"acquired":true,"shares":470,"price":21.046,"value":9891.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 470 shares by the Reporting Person on May 10, 2024 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":14470,"source":{"system":"sec-edgar","filing":"0001415889-24-013356","document":"form4-05162024_040533.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924013356/form4-05162024_040533.xml","form_type":"4"}},{"id":1537510,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2024-04-23T01:51:17.000Z","date":"2024-03-28","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option vest in equal monthly installments over a one year period following the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":4.16,"expiration_date":"2034-03-27","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-24-011353","document":"form4-04232024_010410.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197350/000141588924011353/form4-04232024_010410.xml","form_type":"4"}},{"id":1559552,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-28T00:47:19.000Z","date":"2024-03-27","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":24.8,"value":49600.0,"ownership":{"direct":true},"balance_after":14000,"source":{"system":"sec-edgar","filing":"0001415889-24-009280","document":"form4-03282024_120312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924009280/form4-03282024_120312.xml","form_type":"4"}},{"id":1572488,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-18T21:34:35.000Z","date":"2024-03-18","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":25.8,"value":51600.0,"ownership":{"direct":true},"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001415889-24-008311","document":"form4-03182024_090313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924008311/form4-03182024_090313.xml","form_type":"4"}},{"id":1670980,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-01-26T00:10:23.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."}],"balance_after":8000,"derivative":{"underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001415889-24-001824","document":"form4-01252024_070104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924001824/form4-01252024_070104.xml","form_type":"4"}},{"id":1670979,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-26T00:10:23.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest one year after January 23, 2024 (the \"Vesting Commencement Date\") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."}],"balance_after":32000,"derivative":{"exercise_price":26.49,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001415889-24-001824","document":"form4-01252024_070104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924001824/form4-01252024_070104.xml","form_type":"4"}},{"id":1713028,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T22:55:56.000Z","date":"2023-12-13","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.62,"value":16200.0,"ownership":{"direct":true},"balance_after":142133,"source":{"system":"sec-edgar","filing":"0001209191-23-058544","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919123058544/doc4.xml","form_type":"4"}},{"id":1782997,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-09-12T22:23:25.000Z","date":"2023-09-11","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in a series of three successive equal annual installments beginning on the one year anniversary of September 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in a series of three successive equal annual installments beginning on the one year anniversary of September 11, 2023."}],"balance_after":55000,"derivative":{"underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001209191-23-049133","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919123049133/doc4.xml","form_type":"4"}},{"id":1782996,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-12T22:23:25.000Z","date":"2023-09-11","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares subject to the Option will vest one year after September 11, 2023 (the \"Vesting Commencement Date\") and the balance of the shares will vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting\nCommencement Date."}],"balance_after":110000,"derivative":{"exercise_price":30.43,"expiration_date":"2033-09-10","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001209191-23-049133","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919123049133/doc4.xml","form_type":"4"}},{"id":1782995,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-12T22:23:25.000Z","date":"2023-09-11","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":29.6492,"value":296492.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported on this Form 4 is a weighted average price. The shares were purchased in multiple transactions ranging from $29.61 to $29.65, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth herein."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-23-049133","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919123049133/doc4.xml","form_type":"4"}},{"id":1798971,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-23T22:08:40.000Z","date":"2023-08-21","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.7151,"value":17151.0,"ownership":{"direct":true},"balance_after":132133,"source":{"system":"sec-edgar","filing":"0001209191-23-047110","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919123047110/doc4.xml","form_type":"4"}},{"id":1809761,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-08-11T16:05:37.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8400,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"When granted, each restricted stock unit (\"RSU\") represented a contingent right to receive one share of the Issuer's Common Stock upon settlement."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"When granted, the RSU award provided for the vesting of restricted stock units for shares of the Issuer's Common Stock contingent upon the achievement of certain performance-based vesting conditions.  Pursuant to the Merger Agreement, at the effective time of the Merger, the performance-based RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"When granted, the RSU award provided for the vesting of restricted stock units for shares of the Issuer's Common Stock contingent upon the achievement of certain performance-based vesting conditions.  Pursuant to the Merger Agreement, at the effective time of the Merger, the performance-based RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"When granted, the RSU award provided for the vesting of restricted stock units for shares of the Issuer's Common Stock contingent upon the achievement of certain performance-based vesting conditions.  Pursuant to the Merger Agreement, at the effective time of the Merger, the performance-based RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8400},"source":{"system":"sec-edgar","filing":"0001209191-23-045414","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045414/doc4.xml","form_type":"4"}},{"id":1809760,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-08-11T16:05:37.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":21000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"When granted, each restricted stock unit (\"RSU\") represented a contingent right to receive one share of the Issuer's Common Stock upon settlement."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on January 31, 2024. Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on January 31, 2024. Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on January 31, 2024. Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-23-045414","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045414/doc4.xml","form_type":"4"}},{"id":1809759,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-08-11T16:05:37.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":14667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"When granted, each restricted stock unit (\"RSU\") represented a contingent right to receive one share of the Issuer's Common Stock upon settlement."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on January 31, 2023. Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on January 31, 2023. Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on January 31, 2023. Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14667},"source":{"system":"sec-edgar","filing":"0001209191-23-045414","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045414/doc4.xml","form_type":"4"}},{"id":1809758,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-08-11T16:05:37.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2435,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"When granted, each restricted stock unit (\"RSU\") represented a contingent right to receive one share of the Issuer's Common Stock upon settlement."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on February 10, 2022.  Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on February 10, 2022.  Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on February 10, 2022.  Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2435},"source":{"system":"sec-edgar","filing":"0001209191-23-045414","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045414/doc4.xml","form_type":"4"}},{"id":1809757,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-08-11T16:05:37.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16415,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"When granted, each restricted stock unit (\"RSU\") represented a contingent right to receive one share of the Issuer's Common Stock upon settlement."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on November 30, 2021. Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on November 30, 2021. Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on November 30, 2021. Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16415},"source":{"system":"sec-edgar","filing":"0001209191-23-045414","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045414/doc4.xml","form_type":"4"}},{"id":1809756,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-11T16:05:37.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":84000,"price":14.73,"value":1237320.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This stock option award, which provided for 25% of the award to vest on  January 31, 2024 and ratable vesting in 36 additional monthly installments thereafter, became fully vested and was canceled upon effectiveness of the Merger, and was converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such option, (i) a cash payment representing the excess, if any, of the per share merger consideration ($40.00 per share) over the per share exercise price for such option, without interest, and (ii) one CVR, entitling the reporting person to additional cash payments upon the achievement of certain future business milestones pursuant to the Contingent Value Rights Agreement entered into concurrent with the completion of the Merger, in each case subject to applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":25.27,"expiration_date":"2033-01-30","underlying":"Common Stock","underlying_shares":84000},"source":{"system":"sec-edgar","filing":"0001209191-23-045414","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045414/doc4.xml","form_type":"4"}},{"id":1809755,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-11T16:05:37.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":88000,"price":27.1,"value":2384800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This stock option award, which provided for 25% of the award to vest on January 31, 2023 and ratable vesting in 36 additional monthly installments thereafter, became fully vested and was canceled upon effectiveness of the Merger, and was converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such option, (i) a cash payment representing the excess, if any, of the per share merger consideration ($40.00 per share) over the per share exercise price for such option, without interest, and (ii) one CVR, entitling the reporting person to additional cash payments upon the achievement of certain future business milestones pursuant to the Contingent Value Rights Agreement entered into concurrent with the completion of the Merger, in each case subject to applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":12.9,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":88000},"source":{"system":"sec-edgar","filing":"0001209191-23-045414","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045414/doc4.xml","form_type":"4"}},{"id":1809754,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-11T16:05:37.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":21501,"price":24.86,"value":534514.86,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option award, which provided for 25% of the award to vest on February 10, 2022 and ratable vesting in 36 additional monthly installments thereafter, became fully vested and was canceled upon effectiveness of the Merger, and was converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such option, (i) a cash payment representing the excess, if any, of the per share merger consideration ($40.00 per share) over the per share exercise price for such option, without interest, and (ii) one CVR, entitling the reporting person to additional cash payments upon the achievement of certain future business milestones pursuant to the Contingent Value Rights Agreement entered into concurrent with the completion of the Merger, in each case subject to applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":15.14,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":21501},"source":{"system":"sec-edgar","filing":"0001209191-23-045414","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045414/doc4.xml","form_type":"4"}},{"id":1809753,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-11T16:05:37.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":144787,"price":26.02,"value":3767357.74,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option award, which provided for 25% of the award to vest on November 30, 2021 and ratable vesting in 36 additional monthly installments thereafter, became fully vested and was canceled upon effectiveness of the Merger, and was converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such option, (i) a cash payment representing the excess, if any, of the per share merger consideration ($40.00 per share) over the per share exercise price for such option, without interest, and (ii) one CVR, entitling the reporting person to additional cash payments upon the achievement of certain future business milestones pursuant to the Contingent Value Rights Agreement entered into concurrent with the completion of the Merger, in each case subject to applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":13.98,"expiration_date":"2030-11-29","underlying":"Common Stock","underlying_shares":144787},"source":{"system":"sec-edgar","filing":"0001209191-23-045414","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045414/doc4.xml","form_type":"4"}},{"id":1809752,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-11T16:05:37.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":39371,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The number of shares reported includes 504 shares of the Issuer's Common Stock acquired, since that date of the reporting person's previous Form 4 filing, pursuant to the Issuer's employee stock purchase plan in transactions exempt from reporting under Rules 16b-3(c) and 16b-3(d)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities were disposed of pursuant to the Merger Agreement (defined in the Remarks below).  Upon effectiveness of the Merger (defined in the Remarks below), in exchange for each share of the Issuer's Common Stock, the reporting person received:  (i) $40.00 in cash, without interest and less applicable withholding taxes; and (ii) one contractual contingent value right (each, a \"CVR\"), entitling the reporting person to additional cash payments upon the achievement of certain future business milestones pursuant to the Contingent Value Rights Agreement (the \"Contingent Value Rights Agreement\") entered into concurrent with completion of the Merger."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-045414","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045414/doc4.xml","form_type":"4"}},{"id":1842599,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2023-06-28T23:49:32.000Z","date":"2023-05-08","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option vest in equal monthly installments over a three year period following the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":3.25,"expiration_date":"2033-05-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-040095","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197350/000120919123040095/doc4.xml","form_type":"4"}},{"id":1861170,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-09T20:07:23.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":5,"value":200000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":122133,"source":{"system":"sec-edgar","filing":"0001209191-23-035749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919123035749/doc4.xml","form_type":"4"}},{"id":1871738,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-01T23:48:06.000Z","date":"2023-05-31","kind":"purchase","planned":false,"acquired":true,"shares":150,"price":4.2,"value":630.0,"ownership":{"direct":true},"balance_after":3684,"source":{"system":"sec-edgar","filing":"0001209191-23-033460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1197350/000120919123033460/doc4.xml","form_type":"4"}},{"id":1871737,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-01T23:48:06.000Z","date":"2023-05-31","kind":"purchase","planned":false,"acquired":true,"shares":100,"price":4.0875,"value":408.75,"ownership":{"direct":true},"balance_after":3534,"source":{"system":"sec-edgar","filing":"0001209191-23-033460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197350/000120919123033460/doc4.xml","form_type":"4"}},{"id":1871736,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-01T23:48:06.000Z","date":"2023-05-30","kind":"purchase","planned":false,"acquired":true,"shares":5,"price":3.25,"value":16.25,"ownership":{"direct":true},"balance_after":3434,"source":{"system":"sec-edgar","filing":"0001209191-23-033460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197350/000120919123033460/doc4.xml","form_type":"4"}},{"id":1879549,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-25T00:16:31.000Z","date":"2023-05-23","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":3.268,"value":1634.0,"ownership":{"direct":true},"balance_after":3429,"source":{"system":"sec-edgar","filing":"0001209191-23-032025","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197350/000120919123032025/doc4.xml","form_type":"4"}},{"id":1881525,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-23T21:57:45.000Z","date":"2023-05-23","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":2,"value":10000.0,"ownership":{"direct":true},"balance_after":82133,"source":{"system":"sec-edgar","filing":"0001209191-23-031710","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919123031710/doc4.xml","form_type":"4"}},{"id":1882318,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-22T20:32:37.000Z","date":"2023-05-19","kind":"purchase","planned":false,"acquired":true,"shares":199,"price":2.65,"value":527.35,"ownership":{"direct":true},"balance_after":2929,"source":{"system":"sec-edgar","filing":"0001209191-23-031472","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197350/000120919123031472/doc4.xml","form_type":"4"}},{"id":1882317,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-22T20:32:37.000Z","date":"2023-05-18","kind":"purchase","planned":false,"acquired":true,"shares":1,"price":2.65,"value":2.65,"ownership":{"direct":true},"balance_after":2730,"source":{"system":"sec-edgar","filing":"0001209191-23-031472","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197350/000120919123031472/doc4.xml","form_type":"4"}},{"id":1884270,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2023-05-19T20:09:48.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20000,"derivative":{"exercise_price":0.56,"exercise_date":"2023-06-18","expiration_date":"2033-05-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001593968-23-000837","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197350/000159396823000837/primary_01.xml","form_type":"4"}},{"id":1886635,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-18T22:08:19.000Z","date":"2023-05-18","kind":"purchase","planned":false,"acquired":true,"shares":300,"price":2.7,"value":810.0,"ownership":{"direct":true},"balance_after":2729,"source":{"system":"sec-edgar","filing":"0001209191-23-030782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1197350/000120919123030782/doc4.xml","form_type":"4"}},{"id":1886634,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-18T22:08:19.000Z","date":"2023-05-17","kind":"purchase","planned":false,"acquired":true,"shares":200,"price":2.67,"value":534.0,"ownership":{"direct":true},"balance_after":2429,"source":{"system":"sec-edgar","filing":"0001209191-23-030782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197350/000120919123030782/doc4.xml","form_type":"4"}},{"id":1886633,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-18T22:08:19.000Z","date":"2023-05-16","kind":"purchase","planned":false,"acquired":true,"shares":800,"price":2.7,"value":2160.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $2.70, and the range of prices were between $2.605 and $2.76. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":2229,"source":{"system":"sec-edgar","filing":"0001209191-23-030782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197350/000120919123030782/doc4.xml","form_type":"4"}},{"id":1937779,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-03-27T23:55:27.000Z","date":"2023-03-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1429,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 14-to-1 reverse stock split effective March 17, 2023. Under the terms of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended (the \"Merger Agreement\"), by and among CalciMedica, Inc. (\"Private CalciMedica\"), the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\"), on March 20, 2023, Merger Sub merged with and into Private CalciMedica (the \"Merger\"), with Private CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common capital stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. In connection with the Merger, the vesting of Eric Bjerkholt's options and restricted stock units (\"RSUs\") were fully accelerated and the RSUs were settled on March 23, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a 14-to-1 reverse stock split effective March 17, 2023. Under the terms of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended (the \"Merger Agreement\"), by and among CalciMedica, Inc. (\"Private CalciMedica\"), the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\"), on March 20, 2023, Merger Sub merged with and into Private CalciMedica (the \"Merger\"), with Private CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common capital stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. In connection with the Merger, the vesting of Eric Bjerkholt's options and restricted stock units (\"RSUs\") were fully accelerated and the RSUs were settled on March 23, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects a 14-to-1 reverse stock split effective March 17, 2023. Under the terms of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended (the \"Merger Agreement\"), by and among CalciMedica, Inc. (\"Private CalciMedica\"), the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\"), on March 20, 2023, Merger Sub merged with and into Private CalciMedica (the \"Merger\"), with Private CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common capital stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. In connection with the Merger, the vesting of Eric Bjerkholt's options and restricted stock units (\"RSUs\") were fully accelerated and the RSUs were settled on March 23, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reflects a 14-to-1 reverse stock split effective March 17, 2023. Under the terms of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended (the \"Merger Agreement\"), by and among CalciMedica, Inc. (\"Private CalciMedica\"), the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\"), on March 20, 2023, Merger Sub merged with and into Private CalciMedica (the \"Merger\"), with Private CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common capital stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. In connection with the Merger, the vesting of Eric Bjerkholt's options and restricted stock units (\"RSUs\") were fully accelerated and the RSUs were settled on March 23, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1429},"source":{"system":"sec-edgar","filing":"0001209191-23-021298","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197350/000120919123021298/doc4.xml","form_type":"4"}},{"id":1937778,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-27T23:55:27.000Z","date":"2023-03-23","kind":"disposition_to_issuer","planned":false,"acquired":true,"shares":1429,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a 14-to-1 reverse stock split effective March 17, 2023. Under the terms of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended (the \"Merger Agreement\"), by and among CalciMedica, Inc. (\"Private CalciMedica\"), the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\"), on March 20, 2023, Merger Sub merged with and into Private CalciMedica (the \"Merger\"), with Private CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common capital stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. In connection with the Merger, the vesting of Eric Bjerkholt's options and restricted stock units (\"RSUs\") were fully accelerated and the RSUs were settled on March 23, 2023."}],"balance_after":1429,"source":{"system":"sec-edgar","filing":"0001209191-23-021298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197350/000120919123021298/doc4.xml","form_type":"4"}},{"id":2013466,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-15T16:41:40.000Z","date":"2023-02-10","kind":"exercise","acquired":false,"shares":2435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on February 10, 2022, until fully vested, subject to the reporting person's provision of service to the Issuer on each vesting date."}],"balance_after":2435,"derivative":{"expiration_date":"2024-02-10","underlying":"Common Stock","underlying_shares":2435},"source":{"system":"sec-edgar","filing":"0001209191-23-009776","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123009776/doc4.xml","form_type":"4"}},{"id":2013465,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-15T16:41:40.000Z","date":"2023-02-10","kind":"sale","acquired":false,"shares":857,"price":23.7485,"value":20352.4645,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":38867,"source":{"system":"sec-edgar","filing":"0001209191-23-009776","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123009776/doc4.xml","form_type":"4"}},{"id":2013464,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-15T16:41:40.000Z","date":"2023-02-10","kind":"exercise","acquired":true,"shares":2435,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":39724,"source":{"system":"sec-edgar","filing":"0001209191-23-009776","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123009776/doc4.xml","form_type":"4"}},{"id":2035829,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-02-02T18:14:31.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on January 31, 2024, until fully vested, subject to the reporting person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on January 31, 2024, until fully vested, subject to the reporting person's provision of service to the Issuer on each vesting date."}],"balance_after":21000,"derivative":{"underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-23-006373","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123006373/doc4.xml","form_type":"4"}},{"id":2035828,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-02T18:14:31.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":84000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests as to 25% of the total shares on January 31, 2024, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":84000,"derivative":{"exercise_price":25.27,"expiration_date":"2033-01-30","underlying":"Common Stock","underlying_shares":84000},"source":{"system":"sec-edgar","filing":"0001209191-23-006373","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123006373/doc4.xml","form_type":"4"}},{"id":2035827,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unirt","published_at":"2023-02-02T18:14:31.000Z","date":"2023-01-31","kind":"exercise","acquired":false,"shares":7333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on January 31, 2023, until fully vested, subject to the reporting person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on January 31, 2023, until fully vested, subject to the reporting person's provision of service to the Issuer on each vesting date."}],"balance_after":14667,"derivative":{"underlying":"Common Stock","underlying_shares":7333},"source":{"system":"sec-edgar","filing":"0001209191-23-006373","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123006373/doc4.xml","form_type":"4"}},{"id":2035826,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-02T18:14:31.000Z","date":"2023-01-31","kind":"sale","acquired":false,"shares":2891,"price":24.6823,"value":71356.5293,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":37289,"source":{"system":"sec-edgar","filing":"0001209191-23-006373","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123006373/doc4.xml","form_type":"4"}},{"id":2035825,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-02T18:14:31.000Z","date":"2023-01-31","kind":"exercise","acquired":true,"shares":7333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":40180,"source":{"system":"sec-edgar","filing":"0001209191-23-006373","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123006373/doc4.xml","form_type":"4"}},{"id":2098135,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-12-02T16:25:44.000Z","date":"2022-11-30","kind":"exercise","acquired":false,"shares":16414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested as to 33.33% of the total shares on November 30, 2021 and November 30, 2022, and thereafter vests as to 33.33% of the total RSUs on November 30, 2023, subject to the provision of services to the Company on each vesting date."}],"balance_after":16415,"derivative":{"expiration_date":"2023-11-30","underlying":"Common Stock","underlying_shares":16414},"source":{"system":"sec-edgar","filing":"0001209191-22-059415","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919122059415/doc4.xml","form_type":"4"}},{"id":2098134,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-02T16:25:44.000Z","date":"2022-12-01","kind":"sale","acquired":false,"shares":5770,"price":22.288,"value":128601.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":32847,"source":{"system":"sec-edgar","filing":"0001209191-22-059415","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919122059415/doc4.xml","form_type":"4"}},{"id":2098133,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-02T16:25:44.000Z","date":"2022-11-30","kind":"exercise","acquired":true,"shares":16414,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSU\") convert into common stock on a one-for-one basis."}],"balance_after":38617,"source":{"system":"sec-edgar","filing":"0001209191-22-059415","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919122059415/doc4.xml","form_type":"4"}},{"id":2244110,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-03T21:32:49.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's Common Stock, subject to the reporting person's continued status as a service provider to the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The award vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of\nits stockholders, subject to the reporting person's continuous service to the issuer on such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-034252","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1197350/000120919122034252/doc4.xml","form_type":"4"}},{"id":2244109,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-03T21:32:49.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The award vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of\nits stockholders, subject to the reporting person's continuous service to the issuer on such date."}],"balance_after":20000,"derivative":{"exercise_price":0.984,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-034252","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1197350/000120919122034252/doc4.xml","form_type":"4"}},{"id":2245803,"issuer":{"id":5431,"kind":"organization","name":"CERUS CORP"},"owners":[{"id":24148,"kind":"person","name":"BJERKHOLT ERIC","position":1,"cik":"0001197350","reported_name":"BJERKHOLT ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2022-06-03T21:08:53.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":39866,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest one year from the date of grant."}],"balance_after":39866,"derivative":{"exercise_price":4.84,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":39866},"source":{"system":"sec-edgar","filing":"0001209191-22-034203","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1020214/000120919122034203/doc4.xml","form_type":"4"}}],"next_cursor":"2022-06-03T21:08:53.000000Z,2245803"}